tetano
Editor, Senior Moderator
Mol Neurobiol
. 2020 Sep 26.
doi: 10.1007/s12035-020-02149-0. Online ahead of print.
A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View
Hamid Soltani Zangbar[SUP] 1 2 [/SUP], Ali Gorji[SUP] 3 4 5 [/SUP], Tahereh Ghadiri[SUP] 6 7 [/SUP]
Affiliations
Abstract
There is increasing evidence of neurological manifestations and complications in patients with coronavirus disease 19 (COVID-19). More than one-quarter of patients with COVID-19 developed various neurological symptoms, ranging from headache and dizziness to more serious medical conditions, such as seizures and stroke. The recent investigations introduced hyposmia as a potential early criterion of infection with COVID-19. Despite the high mortality and morbidity rate of COVID-19, its exact mechanism of action and pathogenesis is not well characterized. The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could interact with angiotensin-converting enzyme 2 (ACE2) in the endothelial, neural, and glial cells. In the present study, we reviewed the most common neurological manifestations and complications that emerged after infection with the SARS-CoV-2 and discussed their possible relation to the expression and function of ACE2. Comprehensive and detailed studies are required to uncover how this virus invades the neural system as well as other critical organs.
Keywords: ACE2; Angiotensin; Brain; COVID-19; Cytokine; Vascular.
. 2020 Sep 26.
doi: 10.1007/s12035-020-02149-0. Online ahead of print.
A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View
Hamid Soltani Zangbar[SUP] 1 2 [/SUP], Ali Gorji[SUP] 3 4 5 [/SUP], Tahereh Ghadiri[SUP] 6 7 [/SUP]
Affiliations
- PMID: 32981023
- DOI: 10.1007/s12035-020-02149-0
Abstract
There is increasing evidence of neurological manifestations and complications in patients with coronavirus disease 19 (COVID-19). More than one-quarter of patients with COVID-19 developed various neurological symptoms, ranging from headache and dizziness to more serious medical conditions, such as seizures and stroke. The recent investigations introduced hyposmia as a potential early criterion of infection with COVID-19. Despite the high mortality and morbidity rate of COVID-19, its exact mechanism of action and pathogenesis is not well characterized. The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could interact with angiotensin-converting enzyme 2 (ACE2) in the endothelial, neural, and glial cells. In the present study, we reviewed the most common neurological manifestations and complications that emerged after infection with the SARS-CoV-2 and discussed their possible relation to the expression and function of ACE2. Comprehensive and detailed studies are required to uncover how this virus invades the neural system as well as other critical organs.
Keywords: ACE2; Angiotensin; Brain; COVID-19; Cytokine; Vascular.